Investment in quality management can reduce defects and recalls, FDA says
Regulatory NewsJoanne S. Eglovitch
CDERGMPManufacturingPharmaceuticalsProject managementQuality Assurance and ControlQuality management system/QMSRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)